「内因性オピオイド」の版間の差分
細編集の要約なし |
細 →前駆体 |
||
| 41行目: | 41行目: | ||
| [[Met-エンケファリン]] || YGGFM || δ-オピオイド受容体<sup>†</sup>、μ-オピオイド受容体<sup>†</sup> || <ref name="Endogenous opioid families - 2012 review" /><ref name="IUPHAR Opioid receptors - Introduction" /><ref name="IUPHAR - δ-opioid receptor" /> | | [[Met-エンケファリン]] || YGGFM || δ-オピオイド受容体<sup>†</sup>、μ-オピオイド受容体<sup>†</sup> || <ref name="Endogenous opioid families - 2012 review" /><ref name="IUPHAR Opioid receptors - Introduction" /><ref name="IUPHAR - δ-opioid receptor" /> | ||
|- | |- | ||
| [[メトルファミド]] | | [[メトルファミド]] || YGGFMRRV-NH<sub>2</sub> || δ-オピオイド受容体、μ-オピオイド受容体 || <ref name="Endogenous opioid families - 2012 review" /> | ||
|- | |- | ||
| [[ペプチドE]] || YGGFMRRVGRPEWWMDYQKRYGGFL || μ-オピオイド受容体、[[κ-オピオイド受容体]] || <ref name="Endogenous opioid families - 2012 review" /> | | [[ペプチドE]] || YGGFMRRVGRPEWWMDYQKRYGGFL || μ-オピオイド受容体、[[κ-オピオイド受容体]] || <ref name="Endogenous opioid families - 2012 review" /> | ||